March 10, 2020 - Outsourcing Pharma
The purchase is aimed at expanding the company’s specialty diagnostics offerings in sample preparation technology, assay capabilities, bioinformatics and more.
March 10, 2020 - Outsourcing Pharma
The acquired company specializes in conducting clinical trials for depression, anxiety, bipolar disorder and other central nervous system conditions.
March 10, 2020 - BioPharma Dive
The Food and Drug Administration is postponing inspections of overseas manufacturing plants and facilities supplying drugs to the U.S. except for those deemed "mission critical." The decision was based on travel restrictions and advisories put in place by the federal government in response to the global spread of the new coronavirus.
"Alternative tools and methods" will be used to maintain oversight of foreign manufacturers and products, the FDA said in Tuesday statement. The regulator acknowledged the move could affect its reviews of experimental drugs, however.
March 9, 2020 - BioPharma Dive
The new coronavirus is moving quickly around the world. Since December, when it was first identified in Wuhan, China, the virus has spread to more than 100 countries. Some 105,000 cases have been confirmed, though the true number is surely higher, and at least 3,500 people have died. Already, the virus known as SARS-CoV-2 is straining healthcare systems in the hardest-hit regions, and threatens to do the same elsewhere as the infection total grows.
A handful of drugmakers have started work on vaccines to protect against the virus or medicines to treat the illness it causes — named coronavirus disease 2019, or COVID-19. Hundreds of studies are underway in search of an effective treatment, testing mostly repurposed HIV or influenza drugs. Yet it will likely be many months or even years, if at all, before one designed specifically for SARS-CoV-2 becomes available. Current treatment consists mostly of supportive care.
